Bridgeway Capital Management’s Medifast MED Stock Holding History

Bridgeway Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Sell	117,078 -40,000	-25%	-$461K	0.02%	694
2026 Q1	$1.6M	Buy	157,078 +39,139	+33%	+$422K	0.03%	586
2025 Q4	$1.26M	Sell	117,939 -538	-0.5%	-$6.44K	0.03%	656
2025 Q3	$1.62M	Buy	118,477 +60,533	+104%	+$846K	0.03%	604
2025 Q2	$814K	Buy	57,944 +36,044	+165%	+$474K	0.02%	688
2025 Q1	$295K	Buy	21,900 +1,900	+10%	+$28.5K	0.01%	843
2024 Q4	$352K	Buy	+20,000	New	+$371K	0.01%	887
2019 Q4	–	Sell	-3,500	Closed	-$363K	–	1364
2019 Q3	$363K	Hold	3,500	–	–	0.01%	1052
2019 Q2	$449K	Hold	3,500	–	–	0.01%	1008
2019 Q1	$446K	Hold	3,500	–	–	0.01%	1053
2018 Q4	$438K	Sell	3,500 -400	-10%	-$68.4K	0.01%	1039
2018 Q3	$864K	Sell	3,900 -1,100	-22%	-$223K	0.01%	945
2018 Q2	$801K	Hold	5,000	–	–	0.01%	963
2018 Q1	$467K	Hold	5,000	–	–	0.01%	1114
2017 Q4	$349K	Sell	5,000 -150	-3%	-$9.95K	﹤0.01%	1178
2017 Q3	$306K	Hold	5,150	–	–	﹤0.01%	1199
2017 Q2	$214K	Buy	+5,150	New	+$224K	﹤0.01%	1277

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bridgeway Capital Management's MED Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Medifast (MED) stake by 25% in Q2 2026, selling an estimated $461K and leaving 117,078 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #694.

Bridgeway Capital Management first reported a position in MED in Q2 2017 and has held it in 17 quarters since. The position peaked at $1.62M in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Bridgeway Capital Management held 117,078 shares of Medifast worth $1.24M as of Q2 2026.
Bridgeway Capital Management sold 40,000 Medifast shares in Q2 2026, an estimated $461K.
Medifast made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #694 holding.
Bridgeway Capital Management first reported a position in Medifast in Q2 2017 and has held it in 17 quarters since.
Bridgeway Capital Management's Medifast position peaked at $1.62M in Q3 2025.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.